A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms /

This report for the National Cancer Policy Board (NCPB) describes the procedures currently in place in the United States for approving and monitoring clinical trials of cancer treatments. Virtually all cancer clinical trials are funded by agencies of the federal government or the pharmaceutical indu...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Gelband, Hellen
Autor Corporativo: National Cancer Policy Board (U.S.)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington D.C. : National Research Council, 1999.
Temas:
Cancer > Treatment.
Oncology > Research.
Clinical trials.
Neoplasms > therapy
Clinical Trials as Topic
Clinical Trials as Topic > standards
Cancer > Traitement.
Cancérologie > Recherche.
Études cliniques.
MEDICAL > Preventive Medicine.
MEDICAL > Forensic Medicine.
MEDICAL > Public Health.
United States
Acceso en línea:Texto completo
Descripción
Sumario:This report for the National Cancer Policy Board (NCPB) describes the procedures currently in place in the United States for approving and monitoring clinical trials of cancer treatments. Virtually all cancer clinical trials are funded by agencies of the federal government or the pharmaceutical industry, so the focus is on the requirements for each of these groups. The paper is intended as a jumping off point for the NCPB to consider some of the pressing policy issues surrounding clinical trials in cancer, though as yet, no specific follow-on projects have been initiated.
Notas:Title from caption (viewed June 14, 2001).
"February 1999."
Descripción Física:1 online resource
Bibliografía:Includes bibliographical references.
ISBN:0309583012
9780309583015

Ejemplares similares